Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4113131

ENSARTINIB
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
C[C@@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@H](C)N1

Basic Information

ChEMBL ID CHEMBL4113131
Name ENSARTINIB
Phase Approved
Structure Type MOL
InChI Key GLYMPHUVMRFTFV-QLFBSQMISA-N
Therapeutic ✓ Yes

Known Names

Ensacove Ensartinib X-396
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
3
Known Names
3
Indications
1
Mechanisms

Molecular Properties

561.5
MW (Da)
4.72
ALogP
7
HBA
3
HBD
122.5
PSA (Ų)
0.37
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2024
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral
USAN Stem -tinib
USAN Year 2017

Extended Properties

Molecular Formula C26H27Cl2FN6O3
MW 561.45
Aromatic Rings 3
Heavy Atoms 38
NP-Likeness -1.18

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
ALK tyrosine kinase receptor inhibitor INHIBITOR ALK tyrosine kinase receptor

Indications

Carcinoma, Non-Small-Cell Lung Lung Neoplasms Melanoma

Activity Summary

IC50 2 meas. best 9.13

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Hepatocyte growth factor receptor
CHEMBL3717
IC50 9.13 9.13 0.7 1
NCI-H3122
CHEMBL4296475
IC50 7.82 7.82 15.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
31419130 10.1021/acs.jmedchem.9b00446 NCI-H3122 2
31419130 10.1021/acs.jmedchem.9b00446 ALK tyrosine kinase receptor 1
31419130 10.1021/acs.jmedchem.9b00446 Hepatocyte growth factor receptor 1

Data from ChEMBL 36 via Core Engine